A detailed history of Vontobel Holding Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Vontobel Holding Ltd. holds 1,025,674 shares of BMY stock, worth $59.1 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
1,025,674
Previous 983,218 4.32%
Holding current value
$59.1 Million
Previous $40.8 Million 29.99%
% of portfolio
0.18%
Previous 0.14%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$39.66 - $51.75 $1.68 Million - $2.2 Million
42,456 Added 4.32%
1,025,674 $53.1 Million
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $2.65 Million - $3.49 Million
-65,906 Reduced 6.28%
983,218 $40.8 Million
Q1 2024

May 10, 2024

SELL
$47.98 - $54.4 $39.6 Million - $44.9 Million
-825,985 Reduced 44.05%
1,049,124 $56.9 Million
Q4 2023

Jun 03, 2024

SELL
$48.48 - $57.85 $43.1 Million - $51.4 Million
-888,942 Reduced 45.92%
1,046,980 $53.7 Million
Q4 2023

Jan 29, 2024

SELL
$48.48 - $57.85 $86.2 Million - $103 Million
-1,778,042 Reduced 48.67%
1,875,109 $96.2 Million
Q3 2023

Jun 03, 2024

BUY
$57.89 - $64.73 $15.4 Million - $17.2 Million
266,112 Added 15.94%
1,935,922 $112 Million
Q3 2023

Oct 10, 2023

BUY
$57.89 - $64.73 $30.7 Million - $34.3 Million
530,405 Added 16.99%
3,653,151 $212 Million
Q2 2023

Jun 03, 2024

SELL
$63.71 - $70.74 $12.8 Million - $14.2 Million
-200,192 Reduced 10.71%
1,669,810 $107 Million
Q2 2023

Jul 24, 2023

SELL
$63.71 - $70.74 $25.8 Million - $28.7 Million
-405,239 Reduced 11.49%
3,122,746 $200 Million
Q1 2023

Jun 03, 2024

BUY
$65.71 - $74.53 $53.9 Million - $61.2 Million
820,878 Added 78.24%
1,870,002 $130 Million
Q1 2023

Apr 12, 2023

BUY
$65.71 - $74.53 $111 Million - $126 Million
1,689,785 Added 91.93%
3,527,985 $245 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $13.6 Million - $16.1 Million
198,230 Added 12.09%
1,838,200 $132 Million
Q3 2022

Nov 04, 2022

BUY
$0.13 - $76.84 $13,301 - $7.86 Million
102,316 Added 6.65%
1,639,970 $117 Million
Q2 2022

Jul 27, 2022

SELL
$72.62 - $79.98 $17.4 Million - $19.2 Million
-239,989 Reduced 13.5%
1,537,654 $120 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $49.5 Million - $59.4 Million
805,626 Added 82.88%
1,777,643 $131 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $1.92 Million - $2.23 Million
-35,735 Reduced 3.55%
972,017 $60.8 Million
Q3 2021

Oct 29, 2021

SELL
$59.17 - $69.31 $28.8 Million - $33.7 Million
-485,964 Reduced 32.53%
1,007,752 $59.6 Million
Q2 2021

Aug 06, 2021

BUY
$61.91 - $67.42 $29.7 Million - $32.4 Million
480,293 Added 47.39%
1,493,716 $99 Million
Q1 2021

May 11, 2021

BUY
$59.34 - $66.74 $5.84 Million - $6.57 Million
98,389 Added 10.75%
1,013,423 $64 Million
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $52.8 Million - $59.9 Million
915,034 New
915,034 $55.1 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.